# A Study of the Change in Early and Sustained Pain Control in Axial Spondylarthritis in Adult Participants Receiving Upadacitinib

> **NCT04846244** · — · COMPLETED · sponsor: **AbbVie** · enrollment: 708 (actual)

## Conditions studied

- Axial Spondylarthritis (axSpA)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04846244
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-30
- **Primary completion:** 2025-03-24
- **Final completion:** 2025-03-24
- **Target enrollment:** 708 (ACTUAL)
- **Last updated:** 2026-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04846244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04846244, "A Study of the Change in Early and Sustained Pain Control in Axial Spondylarthritis in Adult Participants Receiving Upadacitinib". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT04846244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*